A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Final Diagnosis -- Case 701
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Monoclonal Gammopathy of Undetermined Significance (MGUS), Asymptomatic Multiple Myeloma, and Amyloidosis
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
UHL GP NEWS
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Manni Mohyuddin on Twitter: "There were some simplifications here in this thread, but will be helpful for fellows interpreting these values, and for non-hematologists who place these consults! Thanks for reading, and
Familial Myeloma | NEJM
xmlinkhub
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article